Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
10.99
+0.29 (2.71%)
At close: May 12, 2025, 4:00 PM
11.32
+0.33 (3.00%)
After-hours: May 12, 2025, 6:18 PM EDT
Syndax Pharmaceuticals Employees
Syndax Pharmaceuticals had 270 employees as of December 31, 2024. The number of employees increased by 86 or 46.74% compared to the previous year.
Employees
270
Change (1Y)
86
Growth (1Y)
46.74%
Revenue / Employee
$161,933
Profits / Employee
-$1,226,681
Market Cap
945.66M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SNDX News
- 4 hours ago - Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer - GlobeNewsWire
- 4 days ago - Syndax Announces Participation in May Investor Conferences - GlobeNewsWire
- 5 days ago - Syndax Announces Publication of Pivotal Revumenib Data in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia in the Journal Blood - GlobeNewsWire
- 6 days ago - Syndax Pharmaceuticals, Inc. (SNDX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Syndax Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 10 days ago - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 14 days ago - Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025 - GlobeNewsWire
- 5 weeks ago - Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum - GlobeNewsWire